Minerva Neurosciences, Inc. - Director's Dealing 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-01-04

Reporting Person: Levine Mark S. (SVP,General Counsel & Sec.)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-04	Common Stock	M	17250	$4.71	Acquired	17250	Direct
2017-01-04	Common Stock	M	250	$5.19	Acquired	17500	Direct
2017-01-04	Common Stock	S	17500	$12.00	Disposed	0	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-04	Stock Option (Right to Buy)	$4.71	M	17250	Disposed	2025-12-03	Common Stock (17250)	Direct
2017-01-04	Stock Option (Right to Buy)	$5.19	M	250	Disposed	2025-04-13	Common Stock (250)	Direct

F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016.

F2: This option vests as follows: 25% on December 4, 2016 and then in quarterly installments over 3 years thereafter.

F3: This option vests as follows: 25% on April 14, 2016; and then in quarterly installments over 3 years thereafter.